Interestingly in three (IDH1 R132H: n = 1; IDH2 R140Q: n = 2) out of 93 IDH1/2 negative AML cases where diagnosis and relapse samples were both available, IDH1/2 mutations appeared only at relapse. This evidence concerns the gene IDH1 and acute myeloid leukemia.